Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
5.12
+0.02 (0.39%)
Jan 15, 2025, 10:18 AM EST - Market open
Corvus Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$12.38
Upside
+141.80%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +114.84% | Jan 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +114.84% | Jan 2, 2025 |
Oppenheimer | Oppenheimer | Buy Reiterates $8 → $14 | Buy | Reiterates | $8 → $14 | +173.44% | Nov 13, 2024 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $12 → $21 | Strong Buy | Maintains | $12 → $21 | +310.16% | Sep 16, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +56.25% | May 7, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
Mizuho | Mizuho | Hold Maintains $3.5 | Hold | Maintains | $3.5 | -31.64% | Mar 27, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +36.72% | Mar 20, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $4 | Buy | Reiterates | $4 | -21.88% | Sep 7, 2023 |
Mizuho | Mizuho | Hold Reiterates $3.5 | Hold | Reiterates | $3.5 | -31.64% | Jun 16, 2023 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $4 → $10 | Strong Buy | Maintains | $4 → $10 | +95.31% | May 30, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $2 → $4 | Buy | Maintains | $2 → $4 | -21.88% | May 9, 2023 |
Mizuho | Mizuho | Hold Reiterates $3.5 | Hold | Reiterates | $3.5 | -31.64% | Mar 30, 2023 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | -60.94% | Oct 7, 2022 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +56.25% | Dec 3, 2021 |
Jefferies | Jefferies | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +56.25% | Dec 1, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.